ArticleFood science & nutrition2026
Characterization of Bromelain-Soluble Sheepskin (
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterization of Bromelain-Soluble Sheepskin (Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work characterizes proteins extracted from sheepskin using bromelain and examines angiotensin converting enzyme (ACE) inhibition activity of the peptides generated by in vitro gastrointestinal digestion (GID). Gel electrophoresis revealed three major protein bands corresponding to keratin and collagen. In vitro gastrointestinal digestion facilitated protein breakdown into peptides, yielding below 3 kDa of molecular weight peptides. Arginine, tyrosine, lysine, and leucine were identified as the major residues of amino acids in the bromelain-soluble protein hydrolysate (BSPH). The action of inhibiting ACE of 1 mg/mL of BSPH was 48.99%, whereas the activity of the < 3 kDa ultra-filtrated fractions obtained before and after in vitro GID were 0% and 19.94%, respectively. To acquire the peptide profile and fractionate the ultra-filtrated peptide fractions, reverse-phase high-performance liquid chromatography (RP-HPLC) was utilized. Among all the RP-HPLC fractions, 2, 3, 12, and 15 had the most active ACE inhibition. Subsequently, the peptide sequences from four active fractions were recognized using tandem mass spectrometry (MS/MS) and followed by in silico analysis to examine their bioactivity. Two potent ACE-inhibitory peptide candidates from sheepskin collagen, GPAGPAGPR, and QGPPGPAGPR, were identified by in silico analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.